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Abstract
Objective To examine whether first trimester fetal growth restriction
correlates with cardiovascular outcomes in childhood.
Design Population based prospective cohort study.
Setting City of Rotterdam, the Netherlands.
Participants 1184 children with first trimester fetal crown to rump length
measurements, whose mothers had a reliable first day of their last
menstrual period and a regular menstrual cycle.
Main outcomes measures Body mass index, total and abdominal fat
distribution, blood pressure, and blood concentrations of cholesterol,
triglycerides, insulin, and C peptide at the median age of 6.0 (90% range
5.7-6.8) years. Clustering of cardiovascular risk factors was defined as
having three or more of: high android fat mass; high systolic or diastolic
blood pressure; low high density lipoprotein cholesterol or high
triglycerides concentrations; and high insulin concentrations.
Results One standard deviation score greater first trimester fetal crown
to rump length was associated with a lower total fat mass (−0.30%, 95%
confidence interval −0.57% to −0.03%), android fat mass (−0.07%,
−0.12% to −0.02%), android/gynoid fat mass ratio (−0.53, −0.89 to −0.17),
diastolic blood pressure (−0.43, −0.84 to −0.01, mmHg), total cholesterol
(−0.05, −0.10 to 0, mmol/L), low density lipoprotein cholesterol (−0.04,
−0.09 to 0, mmol/L), and risk of clustering of cardiovascular risk factors
(relative risk 0.81, 0.66 to 1.00) in childhood. Additional adjustment for
gestational age and weight at birth changed these effect estimates only
slightly. Childhood body mass index fully explained the associations of
first trimester fetal crown to rump length with childhood total fat mass.
First trimester fetal growth was not associated with other cardiovascular
outcomes. Longitudinal growth analyses showed that compared with
school age children without clustering of cardiovascular risk factors,
those with clustering had a smaller first trimester fetal crown to rump
length and lower second and third trimester estimated fetal weight but
higher weight growth from the age of 6 months onwards.
Conclusions Impaired first trimester fetal growth is associated with an
adverse cardiovascular risk profile in school age children. Early fetal life
might be a critical period for cardiovascular health in later life.
Introduction
Fetal developmental adaptations in response to adverse
environmental exposures may permanently affect the structure
and function of cardiovascular organs.1 These adaptations may
lead to increased risks of cardiovascular disease in adulthood.1
Human development rates are highest during the first trimester
of pregnancy.2 This period includes the embryonic phase and
is essential for development of fetal cardiovascular and
metabolic organs.3 Therefore, the first trimester of pregnancy
may be a critical period for cardiovascular health in childhood
and adulthood.
In obstetric care practice, first trimester fetal crown to rump
length is commonly used for dating pregnancy, assuming no
growth variation.3 However, among pregnant women with a
known first day of the last menstrual period and a regular cycle,
fetal crown to rump length can be used as a first trimester growth
outcome.4 First trimester fetal growth seems to be influenced
by maternal age, ethnicity, parity, blood pressure, haemoglobin
concentrations, smoking, and folic acid supplement use and is
associated with increased risks of adverse birth outcomes.4-8
Whether first trimester fetal growth restriction is associated with
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risk factors for cardiovascular disease in later life remains
unknown.
In a population based prospective cohort study among 1184
mothers with a known first day of the last menstrual period and
a regular cycle, and their children, we examined the associations
of first trimester fetal crown to rump length with cardiovascular
risk factors in childhood. Cardiovascular outcomes of interest
included bodymass index, body fat distribution, blood pressure,
lipid concentrations, and insulin measures, which are known
risk factors for cardiovascular disease in adulthood and track
from childhood to adulthood.9 10
Methods
Design and population
This study was nested in the Generation R Study, a population
based prospective cohort study from early pregnancy onwards
in Rotterdam, the Netherlands.11 Participating mothers gave
written consent.12 Enrolment in the full Generation R Study was
aimed at early pregnancy but allowed until birth. In total, 8880
mothers were enrolled in the full study during pregnancy. Of
these mothers, 4685 did not have a fetal crown to rump length
measurement, mainly because of a later enrolment in the
study.4 10 Of all 4195 mothers with a fetal crown to rump length
measurement, 2576 were not eligible for the nested study
because their fetal crown to rump length measurements were
not within the range of 10 weeks 0 days to 13 weeks 6 days or
they had an unknown first day of last menstrual period or an
irregular menstrual cycle.4 Of the remaining 1619 eligible
mothers who had a first trimester crown to rump length
measurement, had a known gestational age based on the last
menstrual period, and gave birth to a singleton liveborn child,
1184 participated with their children in detailed follow-up
measurements at the age 6 years (supplementary figure S1).
First trimester fetal crown to rump length
We measured first trimester fetal crown to rump length in the
gestational age range of 10 weeks 0 days to 13 weeks 6 days in
a true mid-sagittal plane with the genital tubercle and the fetal
spine longitudinally in view.4 13 First day of the last menstrual
period came from the referring letter from the community
midwife or hospital.4 We confirmed this date with the mother
at the ultrasound visit and obtained additional information on
the regularity and duration of the menstrual cycle. Intra-class
correlation coefficients for intra-observer and inter-observer
reproducibility of crown to rump length measurements were
0.998 and 0.995.14 As previously described, we constructed
gestational age adjusted standard deviation scores for first
trimester fetal crown to rump length.4
Fetal and childhood growth
We measured second and third trimester fetal head
circumference, abdominal circumference, and femur length to
the nearest millimetre by using standardised ultrasound
procedures.15 We used the Hadlock formula to calculate
estimated fetal weight.16 Sex, date of birth, and birth
anthropometrics (length, weight) came from registries. Well
trained staff in community health centres measured childhood
growth characteristics (weight, length) by using standardised
procedures at the ages of 6, 12, 24, 36, and 48 months.9 For all
fetal, birth, and childhood growth characteristics, we used
reference growth charts to construct standard deviation score
values with a commercially available package (GrowthAnalyser
3.0, Dutch Growth Research Foundation, Rotterdam,
Netherlands).15 17
Childhood cardiovascular outcomes
We invited all children to a dedicated research facility in the
Erasmus UniversityMedical Center, Sophia Children’s Hospital
for detailed measurements at the age of 6 years. We measured
height andweight and calculated bodymass index.Wemeasured
body fat by dual energy x ray absorptiometry (iDXA, General
Electrics, 2008, Madison, WI, USA). We calculated total fat
mass as a percentage of total body weight measured by
absorptiometry. We calculated android and gynoid fat mass as
a percentage of total fat mass, as well as their ratio.18 We used
the android/gynoid fat mass ratio as a measure of body fat
distribution, as we did not measure waist/hip ratio. Higher
waist/hip ratio and android/gynoid fat mass ratio reflect an
adverse body fat distribution and are associated with mortality
in adults and insulin resistance in children, respectively.19 20We
measured systolic and diastolic blood pressure at the right
brachial artery, four times at one minute intervals, by using the
validated automatic sphygmomanometer Datascope Accutor
Plus (Paramus, NJ, USA).21 We selected a cuff with a width
approximately 40% of the arm circumference and long enough
to cover 90% of the arm circumference. We obtained venous
blood samples after 30 minutes’ fasting from the children and
measured total cholesterol, low density lipoprotein cholesterol,
high density lipoprotein cholesterol, triglycerides, insulin, and
C peptide concentrations.
We used the previously described definition of childhood
metabolic syndrome phenotype to define childrenwith clustering
of cardiovascular risk factors.22 We defined children with
clustering of cardiovascular risk factors as those with three or
more of the following components: android fat mass percentage
75th centile or above, systolic or diastolic blood pressure 75th
centile or above; high density lipoprotein cholesterol 25th centile
or below or triglycerides 75th centile or above, and insulin
concentration 75th centile or above. We used android fat mass
percentage as proxy for waist circumference, as waist
circumference was not available.20
Covariates
We obtained information onmaternal age, ethnicity, educational
level, parity, folic acid supplementation, and smoking by
questionnaire at enrolment.11 Maternal height and weight were
measured and body mass index was calculated at enrolment.
We measured maternal blood pressure with the validated
oscillometric sphygmomanometer (OMRONHealthcare Europe
B V, Hoofddorp, Netherlands) and documented the mean value
of two blood pressure readings.23
Statistical analysis
Firstly, we used first trimester fetal crown to rump length
standard deviation scores as a continuous variable, to analyse
the linear associations of first trimester fetal crown to rump
length with childhood outcomes. Using mean plots and one way
analysis of variance tests, we observed that the best fitting trend
lines for these associations were linear. The model fit and
explained variance did not improve with addition of a quadratic
term to the multivariate regression models. To further explore
non-linearity and for presentation purposes, we also categorised
first trimester fetal crown to rump length in fifths and examined
the associations of fifths of first trimester fetal crown to rump
length standard deviation score with childhood outcomes by
using multivariate regression models. For these analyses, we
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constructed standard deviation score values ((observed
value−mean)/SD) for the childhood outcomemeasures to enable
comparison of effect estimates for the different outcomes. We
did not create age adjusted standard deviation scores, as the
childhood outcomes weremeasured in a small age range without
changes in standard deviation.
Secondly, we used different linear regressionmodels to examine
the associations of first trimester fetal crown to rump length
standard deviation score with childhood outcomes and the role
of fetal and childhood growth in these associations. We used
four different models. The basic model was adjusted for duration
of last menstrual cycle and child’s sex and age at outcome
measurement. Childhood height was included in all models on
fat mass outcomes to take account of skeletal growth.24 The
confounder model was additionally adjusted for maternal and
childhood covariates including maternal age, educational level,
ethnicity, parity, pre-pregnancy bodymass index, diastolic blood
pressure, smoking during pregnancy, folic acid supplement use,
and duration of breast feeding. We selected these confounders
on the basis of their associations with the outcomes of interest
or a change in effect estimate of more than 10%. Supplementary
tables S1-S3 show the associations of each confounder with the
outcomes of interest. We considered the confounder models to
be the main models. Next, these models were additionally
adjusted for gestational age at birth and birth weight to explore
whether any association was explained by later fetal growth
(fetal pathway model) and for child’s current body mass index
to explore whether any association was explained by current
childhood size (childhood pathway model).
Thirdly, we examined the association of first trimester fetal
crown to rump length standard deviation scores continuously
and in fifths with the risk of childhood clustering of
cardiovascular risk factors. We used a multivariate generalised
linear model with a Poisson assumption, log linear link function,
and robust standard errors estimation to calculate adjusted
relative risks.25 Subsequently, we explored the longitudinal
length and weight growth patterns from first trimester onwards
until the age of 6 years for children with and without clustering
of cardiovascular risk factors. For this analysis, we used repeated
measurement regression models, which take into account the
correlation between repeated growth measurements of the same
participant.26 27
For all analyses, the percentages of missing values of covariates
were lower than 20%.We imputedmissing data of the covariates
by using multiple imputations.28 Five datasets were created and
analysed together. We used SAS version 9.2 for the repeated
measurement analysis and SPSS 17.0 for other analyses.
Results
Participants’ characteristics and
non-response
Table 1⇓ shows the maternal, fetal, and childhood
characteristics. The specific fetal and childhood growth
characteristics are shown in supplementary table S4. As only
mothers with fetal crown to rump length measurement between
10 and14 weeks of gestation and a known and reliable first day
of last menstrual period were eligible for this analysis, we did
several non-response analyses. Supplementary tables S5-S7
show results from these analyses. Compared with mothers with
a first trimester fetal crown to rump length measurement
(n=4195), those without this measurement (n=4685) were on
average younger, shorter, and heavier; had a lower blood
pressure; and were less frequently highly educated and
European. We found no difference in birth weight (table S5).
Amongmothers with a first trimester fetal crown to rump length
measurement, we found similar differences between those
without (n=2576) and with (n=1619) information about their
known last menstruation (table S6). Of the eligible group of
1619 mothers and children, 1184 participated in the follow-up
studies at the age of 6 years. Mothers of children not
participating in these follow-up studies (n=435) were on average
younger, were less frequently higher educated and European,
and less frequently used folic acid supplements. Their children
were more frequently breast fed. We found no differences in
gestational age and weight at birth (table S7).
First trimester fetal crown to rump length and
cardiovascular risk factors
Figure 1⇓ shows that compared with children in the highest fifth
of first trimester fetal crown to rump length, those in the lowest
fifth tended to have higher total fat mass percentage,
android/gynoid fat mass ratio, diastolic blood pressure, and total
cholesterol (all P for trend <0.05). First trimester fetal crown
to rump length was not associated with insulin or C peptide
concentrations. Results for C-peptide are not shown. Table 2⇓
shows that in the confounder models, one standard deviation
score greater first trimester fetal crown to rump length was
associated with a lower total fat mass (−0.30%, 95% confidence
interval −0.57% to −0.03%), android fat mass (−0.07%, −0.12%
to −0.02%), android/gynoid fat mass ratio (−0.53, −0.89 to
−0.17), diastolic blood pressure (−0.43, −0.84 to −0.01, mm
Hg), total cholesterol (−0.05, −0.10 to 0, mmol/L), and low
density lipoprotein cholesterol (−0.04, −0.09 to 0, mmol/L) in
childhood. Additional adjustment for gestational age and weight
at birth only slightly changed these effect estimates. Childhood
body mass index fully explained the associations of first
trimester fetal crown to rump length with childhood total fat
mass. First trimester fetal crown to rump length was not
associated with childhood body mass index, systolic blood
pressure, or concentrations of triglycerides or insulin.
First trimester fetal crown to rump length and
clustering of cardiovascular risk factors
One standard deviation score greater first trimester fetal crown
to rump length was associated with a lower risk of clustering
of cardiovascular risk factors (relative risk 0.81, 95% confidence
interval 0.66 to 1.00) in childhood (fig 2⇓). When we compared
fifths, we observed that compared with children in the lowest
fifth of first trimester fetal crown to rump length, those in the
highest fifth tended to have lower risks of clustering of
cardiovascular risk factors (15.5% v 5.6% for lowest and highest
fifth; relative risk 0.50, 0.22 to 1.10) (fig 2⇓). Adjustment for
gestational age andweight at birth changed these effect estimates
only slightly (supplementary figure S2).
Figure 3⇓ shows the longitudinal growth in fetal and childhood
length and weight from first trimester fetal crown to rump length
onwards in children with clustering of cardiovascular risk
factors, compared with those without clustering of
cardiovascular risk factors. First trimester fetal crown to rump
length tended to be smaller in children with clustering of
cardiovascular risk factors (difference −0.16, 95% confidence
interval −0.36 to 0.03 standard deviation scores). Estimated
fetal weight, but not femur length, until birth tended to be
smaller in children with clustering of cardiovascular risk factors.
From the age of 6 months onwards, children with clustering of
cardiovascular risk factors at age 6 years had a higher length
and weight, with larger effect estimates for weight. The effect
estimates were not materially affected by additional adjustment
for potential confounders (supplementary table S8).
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Discussion
We observed that smaller first trimester fetal size was associated
with an adverse body fat distribution, higher diastolic blood
pressure, and an adverse blood cholesterol profile in childhood.
First trimester fetal growth restriction was also associated with
an increased risk of clustering of these cardiovascular risk factors
in childhood. These associations were not explained bymaternal,
birth, and childhood characteristics.
Interpretation of main findings
Adverse fetal exposures may lead to early developmental
adaptations, including changes in the anatomy, physiology, and
metabolism of various organ systems.1 These adaptations may
be beneficial for short term survival but may have adverse
consequences at birth and in later life, such as increased risks
of low birth weight and common diseases in adulthood.1 Studies
showing consistent associations of low birth weight with
increased risks of cardiovascular disease strongly support this
hypothesis.29 30 Clearly, low birth weight is not the causal factor
leading to diseases in later life. Birth weight is merely an
endpoint of different fetal exposures and growth patterns and
the starting point of childhood growth. Most children with a
low birth weight have a catch-up growth leading to a normal
weight from the age of 2 years onwards.31 Longitudinal studies
also showed that the risk of cardiovascular disease is highest
among adults born with a low birth weight who had a high
postnatal weight gain.32 33 These results suggest that a low birth
weight as a result of restricted fetal environment may
specifically lead to cardiovascular disease in later life, when
postnatal life is characterised by a relatively high body mass
index as a result of an affluent environment.1Notmuch is known
about the specific fetal growth patterns leading to cardiovascular
disease in later life.
Rates of growth and development are much higher in fetal life
than in childhood. The highest development rates are in the first
trimester of pregnancy, which includes the embryonic phase.2
Studies in spontaneously conceived pregnancies and in
pregnancies resulting from assisted reproductive technology
observed that first trimester fetal growth restriction was
associated with increased risks of prematurity and small size
for gestational age at birth.4 7 8 We also observed that smaller
first trimester fetal crown to rump length led to compensatory
accelerated childhood growth.4 High rates of childhood weight
gain may subsequently lead to development of cardiovascular
risk factors in later life.
The study reported here shows for the first time that first
trimester fetal crown to rump length is also associated with an
adverse cardiovascular risk profile in childhood. Smaller first
trimester fetal crown to rump length was associated with higher
total fat mass percentage, android/gynoid fat mass ratio, diastolic
blood pressure, and total cholesterol concentration in childhood.
These associations were observed across the full range of first
trimester fetal crown to rump length and not in the extremes
only. Also, these associations were independent of potential
maternal and childhood confounders and were changed only
slightly by adjustment for gestational age and weight at birth
and childhood body mass index. First trimester fetal growth
was not associated with childhood body mass index, systolic
blood pressure, or concentrations of triglycerides, insulin, or C
peptide. The observed associations suggest that the first trimester
of pregnancy is a critical period for cardiovascular health in
later life. Previous studies have shown that risk factors for
cardiovascular disease in childhood track into adulthood and
are related to development of cardiovascular disease in later
life.9 10 34 Thus, cardiovascular disease may have at least part of
its origins in the first trimester of pregnancy or even the
preconception period. The developmental mechanisms that
explain the associations of first trimester fetal growth and risk
factors for cardiovascular disease are not known, but they may
include changes in methylation of DNA and expression of RNA
in response to a suboptimal fetal environment.1 More detailed
first trimester ultrasound studies are needed to assess early
cardiovascular and metabolic developmental adaptations.
The results from this study are important from an aetiological
perspective. They suggest that the first trimester might be a
critical period for cardiovascular and metabolic function.
However, we acknowledge that the observed effect estimates
were small and reflect subclinical changes in cardiovascular
and metabolic function in school age children. None of the
children had known cardiovascular disease. Previous
longitudinal studies have shown tracking of cardiovascular and
metabolic risk factors from childhood to adulthood.9 10 Also,
adiposity in school age children is related to cardiovascular
disease in later life.34 Further follow-up studies are needed to
explore whether suboptimal first trimester development really
is a risk factor for clinically manifest cardiovascular and
metabolic disease in adulthood.
Strengths and limitations
This study was nested in a large population based prospective
cohort study. In the full study, enrolment was aimed at early
pregnancy but allowed until birth.11 As this study was
specifically focused on the long term effects of variation in first
trimester fetal growth, only a subgroup of mothers with a first
trimester fetal crown to rump length measurement between 10
and 14 weeks of gestation and a known and reliable first day of
last menstrual period was eligible. As a result of these necessary
selection criteria, the eligible mothers reflect a small fraction
of the full study population. Of all eligible mothers, 73%
participated with their children in the follow-up studies at the
age of 6 years. The non-response analyses showed that mothers
not included in the analyses were on average younger, shorter,
and heavier; had a lower blood pressure; were less frequently
high educated and European; and less frequently used folic acid
supplements. Their children were more frequently breast fed.
Our effect estimates would be biased if the associations differ
between participants included and not included in the analysis.
Although this seems unlikely, we cannot exclude it. We found
no differences in first trimester fetal crown to rump length or
birth weight between children with and without participation
in the follow-up studies. More importantly, the selection of the
study sample might have affected the generalisability of the
results. The study population is a rather healthy and relatively
highly educated population. Whether the observed associations
are similar in high risk populations should be studied further.
We tested the associations of first trimester fetal crown to rump
length with several cardiovascular andmetabolic outcomes that
track from childhood to adulthood and are risk factors for
cardiovascular disease in adulthood. The large number of
statistical tests that we did may have led to false positive
associations. However, because of the correlations between the
cardiovascular and metabolic outcomes, we did not adjust the
analyses for multiple testing. We measured first trimester fetal
growth by fetal crown to rump length and used the first day of
the last menstrual period to determine gestational age.
Misclassification of gestational age might still be a problem, as
the post-conception age depends on the timing of ovulation and
implantation, which we were unable to measure.35 Several
maternal factors, such as maternal age and smoking, are
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associated with the duration of the follicular phase, after which
ovulation occurs. Recall bias may also affect the dating of the
last menstrual period.36However, all analyses were adjusted for
the duration of last menstrual cycle, which is strongly associated
with the timing of ovulation. Even with a known and reliable
date of last menstrual period, a certain fraction of women with
regular cycles have early or delayed ovulation. We did a
sensitivity analysis with a restriction to participants who had a
gestational age based on last menstruation within seven days
of a gestational age based on crown to rump length (93%). This
analysis did not materially change our effect estimates for the
childhood outcomes. The analyses were adjusted for several
maternal and childhood confounders. Although we observed
that stepwise adjustment for various different potential maternal
and childhood confounders did not strongly change the effect
estimates, residual confounding may still be a concern, as in
any observational study.
Conclusions
These results suggest that the first trimester of pregnancy may
be a critical period for development of cardiovascular risk factors
in later life. The observed associations are primarily important
from an aetiological perspective. Further studies are needed to
identify the underlying causal biological mechanisms and long
term consequences. Future strategies to improve cardiovascular
health may start from early pregnancy onwards or even before
conception.
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What is already known on this topic
Low birth weight is associated with cardiovascular disease in adulthood, but not much is known about the specific critical periods in fetal
life or infancy
The first trimester of pregnancy includes the embryonic phase and is essential for fetal development of cardiovascular and metabolic
organs
The first trimester of pregnancy may be a critical period for cardiovascular health in childhood and adulthood
What this study adds
Impaired first trimester fetal growth is associated with an adverse cardiovascular risk profile in school age children
These associations are independent of growth during the second half of pregnancy and in childhood
First trimester fetal development might be critical for cardiovascular health in later life
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Tables
Table 1| Maternal, fetal, and childhood characteristics (n=1184). Values are numbers (percentages) unless stated otherwise
ValueCharacteristics
Maternal
31.3 (22.7-38.1)Median (90% range) age, years
168.8 (7.0)Mean (SD) height, cm
66.9 (11.8)Mean (SD) pre-pregnancy weight, kg
23.4 (3.9)Mean (SD) pre-pregnancy body mass index, kg/m2
12.4 (10.5-13.9)Median (90% range) gestational age at intake, weeks
116.7 (12.4)Mean (SD) systolic blood pressure, mm Hg
69.1 (9.4)Mean (SD) diastolic blood pressure, mm Hg
717/1179Nulliparous
Education:
507/1155 (43.9)Primary or secondary school
648/1155 (56.1)Higher education
Race/ethnicity:
855/1175 (72.8)Dutch, other European
320/1175 (27.2)Non-European
Smoking habits:
820/1060 (77.4)Non-smoker
240/1060 (22.6)Smoker
Folic acid supplement use:
119/949 (12.5)None
294/949 (31.0)First 10 weeks
536/949 (56.5)Preconception
Fetal
12.4 (11.0-13.9)Median (90% range) gestational age at fetal crown to rump length measurement, weeks
61 (11)Mean (SD) first trimester fetal crown to rump length, cm
Birth and infant
575 (48.6)Male sex
40.1 (37.0-42.0)Median (90% range) gestational age at birth, weeks
3456 (551)Mean (SD) birth weight, g
Ever breast feeding:
80/1046 (7.6)No
966/1046 (92.4)Yes
5.3 (3.8)Mean (SD) breastfeeding duration, months
Childhood
6.0 (5.7-6.8)Median (90% range) age at follow-up, years
119.0 (5.5)Mean (SD) height, cm
22.8 (3.7)Mean (SD) weight, kg
16.1 (1.7)Mean (SD) body mass index, kg/m2
24.6 (5.2)Mean (SD) total fat mass, %
3.8 (0.9)Mean (SD) android fat mass, %
15.3 (1.6)Mean (SD) gynoid fat mass, %
0.25 (0.1)Mean (SD) android/gynoid fat mass ratio
102.6 (8.1)Mean (SD) systolic blood pressure, mm Hg
60.7 (6.8)Mean (SD) diastolic blood pressure, mm Hg
4.2 (0.7)Mean (SD) cholesterol, mmol/L
2.4 (0.6)Mean (SD) low density lipoprotein cholesterol, mmol/L
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Table 1 (continued)
ValueCharacteristics
1.3 (0.3)Mean (SD) high density lipoprotein cholesterol, mmol/L
0.6 (0.2)Mean (SD) high density/low density lipoprotein cholesterol ratio
1.0 (0.4-2.1)Median (90% range) triglycerides, mmol/L
118.2 (25.9-342.4)Median (90% range) insulin, pmol/L
1.0 (0.4-1.9)Median (90% range) C peptide, nmol/L
81/745 (10.9)Cardiovascular risk factor clustering
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Table 2| First trimester fetal growth and childhood cardiovascular risk factors (n=1184)*
Difference (95% CI) in cardiovascular risk factors per SDS change in first trimester fetal crown to rump length
No
Cardiovascular
risk factor P value
Childhood
pathway model§P value
Fetal pathway
model‡P value
Confounder
model†P valueBasic model
——0.10−0.08 (−0.18 to
0.02)
0.38−0.04 (−0.14 to
0.05)
0.23−0.06 (−0.16 to
0.04)
1181Body mass index
(kg/m2)
0.11−0.16 (−0.36 to
0.04)
0.03−0.31 (−0.59 to
−0.04)
0.03−0.30 (−0.57 to
−0.03)
0.01−0.41 (−0.70 to
−0.13)
1152Total fat mass (%)
0.07−0.04 (−0.08 to 0)0.02−0.07 (−0.12 to
−0.01)
0.01−0.07 (−0.12 to
−0.02)
<0.01−0.08 (−0.14 to
−0.03)
1151Android fat mass
(%)
0.170.06 (−0.03 to
0.15)
0.250.05 (−0.04 to
0.14)
0.320.05 (−0.04 to
0.14)
0.270.05 (−0.04 to
0.14)
1151Gynoid fat mass
(%)
0.01−0.38 (−0.68 to
−0.08)
<0.01−0.52 (−0.88 to
−0.16)
<0.01−0.53 (−0.89 to
−0.17)
<0.01−0.62 (−0.98 to
−0.26)
1151Android/gynoid fat
mass ratio
0.96−0.01 (−0.50 to
0.47)
0.74−0.09 (−0.58 to
0.41)
0.69−0.10 (−0.59 to
0.39)
0.39−0.22 (−0.70 to
0.27)
1125Systolic blood
pressure (mm Hg)
0.06−0.40 (−0.81 to
0.02)
0.05−0.42 (−0.84 to 0)0.04−0.43 (−0.84 to
−0.01)
0.02−0.51 (−0.92 to
−0.10)
1125Diastolic blood
pressure (mm Hg)
0.04−0.05 (−0.10 to 0)0.03−0.06 (−0.10 to
−0.01)
0.04−0.05 (−0.10 to 0)0.04−0.05 (−0.10 to 0)794Total cholesterol
(mmol/L)
0.23−0.01 (−0.04 to
0.01)
0.25−0.01 (−0.04 to
0.01)
0.27−0.01 (−0.04 to
0.01)
0.29−0.01 (−0.04 to
0.01)
794HDL cholesterol
(mmol/L)
0.06−0.04 (−0.09 to 0)0.06−0.04 (−0.09 to 0)0.06−0.04 (−0.09 to 0)0.06−0.04 (−0.08 to 0)793LDL cholesterol
(mmol/L)
0.220.01 (−0.01 to
0.03)
0.190.01 (−0.01 to
0.03)
0.210.01 (−0.01 to
0.03)
0.200.01 (−0.01 to
0.02)
786HDL/LDL
cholesterol ratio
0.690.01 (−0.03 to
0.04)
0.760.01 (−0.03 to
0.04)
0.860.00 (−0.03 to
0.04)
0.710.01 (−0.03 to
0.04)
789Triglyceride
(mmol/L)¶
0.63−0.01 (−0.07 to
0.05)
0.54−0.02 (−0.08 to
0.04)
0.49−0.02 (−0.08 to
0.04)
0.66−0.01 (−0.07 to
0.05)
785Insulin (pmol/L)¶
HDL=high density lipoprotein; LDL=low density lipoprotein; SDS=standard deviation score.
*Values are regression coefficients (95% confidence interval) that reflect the difference in childhood outcomes per SDS first trimester crown to rump length. Basic
model was adjusted for duration of last menstrual cycle and child’s sex and age at outcome measurements. Models for fat mass outcomes were additionally
adjusted for current childhood height.
†Confounders include maternal age, educational level, ethnicity, parity, pre-pregnancy body mass index, diastolic blood pressure, smoking during pregnancy, folic
acid supplement use, and breastfeeding duration.
‡Model additionally adjusted for gestational age and weight at birth.
§Model additionally adjusted for childhood current body mass index.
¶Variables were log transformed.
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Figures
Fig 1 First trimester fetal growth and cardiovascular risk factors in childhood (n=1184). Values are linear regression
coefficients (95% CI) that reflect the difference in childhood outcomes, expressed as standard deviation scores (SDS)
between first trimester fetal crown to rump length fifths, and reference group (highest fifth). Estimates are based on multiple
imputed data. Models were adjusted for child’s sex and age at measurement and for maternal duration of last menstrual
cycle, age, educational level, ethnicity, parity, pre-pregnancy body mass index, diastolic blood pressure, smoking during
pregnancy, folic acid supplement use, and duration of breast feeding. Models for total fat mass and android/gynoid fat mass
ratio were additionally adjusted for current childhood height. Trend lines are given only when P for linear trend <0.05
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Fig 2 First trimester fetal growth and clustering of cardiovascular risk factors (n=745). Values are relative risks (95% CI)
from generalised linear models that reflect risk of childhood clustering of cardiovascular risk factors for fifths of first trimester
fetal crown to rump length, compared with reference group (lowest fifth). Estimates are based on multiple imputed data.
Clustering of cardiovascular risk factors was defined as having three or more of android fat mass percentage ≥75th centile,
systolic or diastolic blood pressure ≥75th centile, high density lipoprotein cholesterol ≤25th centile or triglycerides ≥75th
centile, and insulin concentration ≥75th centile.22 Model was adjusted for child’s sex and age at measurement and for
maternal duration of last menstrual cycle, age, educational level, ethnicity, parity, pre-pregnancy body mass index, diastolic
blood pressure, smoking during pregnancy, folic acid supplement use, and duration of breast feeding
Fig 3 Fetal and childhood length and weight growth from first trimester onwards in children with clustering of cardiovascular
risk factors (n=745). Values are regression coefficients (95% confidence interval) that reflect the difference in length and
weight standard deviation score from first trimester onwards for children with clustering of cardiovascular risk factors,
compared with children without such clustering. Models were adjusted for maternal duration of last menstrual cycle and
child’s sex and age at outcome measurements. Length and weight growth characteristics used in the models were: fetal
period—first trimester crown to rump length as both length and weight measure (starting point), second and third trimester
femur length and estimated fetal weight; at birth—length and weight; during childhood—length and weight. Clustering of
cardiovascular risk factors was defined as having three or more of android fat mass percentage ≥75th centile, systolic or
diastolic blood pressure ≥75th centile, high density lipoprotein cholesterol ≤25th centile or triglycerides ≥75th centile, and
insulin concentration ≥75th centile22
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